167 related articles for article (PubMed ID: 38816520)
21. Chemosensory dysfunction, Oral disorders and Oral health-related quality of life in patients with primary Sjögren's syndrome: comparative cross-sectional study.
Šijan Gobeljić M; Milić V; Pejnović N; Damjanov N
BMC Oral Health; 2020 Jul; 20(1):187. PubMed ID: 32620111
[TBL] [Abstract][Full Text] [Related]
22. Peripheral neuropathy and health-related quality of life in patients with primary Sjögren's syndrome: a preliminary report.
Jaskólska M; Chylińska M; Masiak A; Nowicka-Sauer K; Siemiński M; Ziętkiewicz M; Czuszyńska Z; Zdrojewski Z
Rheumatol Int; 2020 Aug; 40(8):1267-1274. PubMed ID: 32172462
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies against C5aR1, C3aR1, CXCR3, and CXCR4 are decreased in primary Sjogren's syndrome.
Yue X; Deng F; Chen J; Yin J; Zheng J; Chen Y; Huang Q; Gao X; Liu Z; Luo J; Müller A; Heidecke H; Riemekasten G; Petersen F; Yu X
Mol Immunol; 2021 Mar; 131():112-120. PubMed ID: 33446393
[TBL] [Abstract][Full Text] [Related]
24. Increased Interleukin-17F is Associated with Elevated Autoantibody Levels and More Clinically Relevant Than Interleukin-17A in Primary Sjögren's Syndrome.
Gan Y; Zhao X; He J; Liu X; Li Y; Sun X; Li Z
J Immunol Res; 2017; 2017():4768408. PubMed ID: 28210632
[TBL] [Abstract][Full Text] [Related]
25. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
[TBL] [Abstract][Full Text] [Related]
26. Sicca symptoms are associated with similar fatigue, anxiety, depression, and quality-of-life impairments in patients with and without primary Sjögren's syndrome.
Milin M; Cornec D; Chastaing M; Griner V; Berrouiguet S; Nowak E; Marhadour T; Saraux A; Devauchelle-Pensec V
Joint Bone Spine; 2016 Dec; 83(6):681-685. PubMed ID: 26774177
[TBL] [Abstract][Full Text] [Related]
27. Viral antigens elicit augmented immune responses in primary Sjögren's syndrome.
Björk A; Thorlacius GE; Mofors J; Richardsdotter Andersson E; Ivanchenko M; Tingström J; James T; Brokstad KA; Cox RJ; Jonsson R; Kvarnström M; Wahren-Herlenius M
Rheumatology (Oxford); 2020 Jul; 59(7):1651-1661. PubMed ID: 31665501
[TBL] [Abstract][Full Text] [Related]
28. Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren's syndrome.
Vriezekolk JE; Geenen R; Hartkamp A; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
J Rheumatol; 2005 Dec; 32(12):2351-5. PubMed ID: 16331762
[TBL] [Abstract][Full Text] [Related]
29. The impact of primary Sjögren's syndrome on female sexual function.
van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H
Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072
[TBL] [Abstract][Full Text] [Related]
30. Antibodies against carbamylated proteins are present in primary Sjögren's syndrome and are associated with disease severity.
Bergum B; Koro C; Delaleu N; Solheim M; Hellvard A; Binder V; Jonsson R; Valim V; Hammenfors DS; Jonsson MV; Mydel P
Ann Rheum Dis; 2016 Aug; 75(8):1494-500. PubMed ID: 26350884
[TBL] [Abstract][Full Text] [Related]
31. Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome.
Lopes AP; Hillen MR; Chouri E; Blokland SLM; Bekker CPJ; Kruize AA; Rossato M; van Roon JAG; Radstake TRDJ
PLoS One; 2018; 13(2):e0193157. PubMed ID: 29447268
[TBL] [Abstract][Full Text] [Related]
32. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
[TBL] [Abstract][Full Text] [Related]
33. Health-related quality of life and psychological status of women with primary Sjögren's syndrome: A cross-sectional study of 304 Chinese patients.
Liu Z; Dong Z; Liang X; Liu J; Xuan L; Wang J; Zhang G; Hao W
Medicine (Baltimore); 2017 Dec; 96(50):e9208. PubMed ID: 29390343
[TBL] [Abstract][Full Text] [Related]
34. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
Uomori K; Nozawa K; Ikeda K; Doe K; Yamada Y; Yamaguchi A; Fujishiro M; Kawasaki M; Morimoto S; Takamori K; Sekigawa I; Chan EK; Takasaki Y
Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
[TBL] [Abstract][Full Text] [Related]
36. Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome.
Sandhya P; Kabeerdoss J; Christudoss P; Arulraj R; Mandal SK; Janardana R; Chebbi PP; Ganesan MP; Mahasampath G; Danda D
Int J Rheum Dis; 2022 Jan; 25(1):61-69. PubMed ID: 34791797
[TBL] [Abstract][Full Text] [Related]
37. The expression of P2X7 receptors on peripheral blood mononuclear cells in patients with primary Sjögren's syndrome and its correlation with anxiety and depression.
Xie B; Chen Y; Zhang S; Wu X; Zhang Z; Peng Y; Huang X
Clin Exp Rheumatol; 2014; 32(3):354-60. PubMed ID: 24480517
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies to Cytosolic 5'-Nucleotidase 1A in Primary Sjögren's Syndrome and Systemic Lupus Erythematosus.
Rietveld A; van den Hoogen LL; Bizzaro N; Blokland SLM; Dähnrich C; Gottenberg JE; Houen G; Johannsen N; Mandl T; Meyer A; Nielsen CT; Olsson P; van Roon J; Schlumberger W; van Engelen BGM; Saris CGJ; Pruijn GJM
Front Immunol; 2018; 9():1200. PubMed ID: 29922285
[TBL] [Abstract][Full Text] [Related]
39. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
Namkoong E; Lee SW; Kim N; Choi Y; Park K
Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
[TBL] [Abstract][Full Text] [Related]
40. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]